Investor Type | Firm |
Type of Fund | VC |
Industries | BioTech • Medical Devices (& Hospital Services) |
Stages | Seed, Startup, Early Stage, Series A, Series B, Series C, Pre-IPO |
Investing | United States • Canada |
Investment Range | €1,000,000 - €15,000,000 |
Founded in 2018, Amplitude Ventures is a Canadian venture capital firm with its headquarters located at Espace CDPQ 3, Place Ville-Marie Suite 12350 Montreal, QC H3B 0E7. The firm primarily invests in biopharma and medical device companies, committed to bringing groundbreaking technologies to patients. They are focused on building world-class Canadian companies, or companies associated with Canadian talent and intellectual property (IP), within precision medicine and next-generation medical devices. Amplitude Ventures is adept in supporting companies in seed, startup, early stage, Series A, Series B, Series C, and Pre-IPO phases with equity investments, offering a minimum investment capacity of $1,000,000 and a maximum of $15,000,000.The fund's investment thesis revolves around leveraging Canada’s rich innovation ecosystem, particularly in precision medicine, involving enhanced diagnostic quality and accuracy, precise treatments, and targeted therapies using antibodies, immunotherapy, and cell & gene therapy. Amplitude Ventures targets acceleration-stage companies, applying a strategic approach to invest capital, leverage networks, and build strategic alliances, thereby attracting necessary team assets for hyper-growth. With decades of experience, they prioritize problems worth solving and scalable solutions.Their approach is encapsulated in their dedicated platform, Pre-Amp, which focuses on discovering, incubating, and funding innovation with significant potential. Alongside this, the Amplitude Fellowship program supports promising health-focused Ph.D. candidates, postdocs, and MDs to explore innovative biotech concepts.The Amplitude team consists of experienced professionals in health investment and company builders who intend to impact lives by uniting innovators, capital, and entrepreneurial expertise. They have a track record of aiding companies from inception through growth phases towards successful exits, including IPOs. Their portfolio showcases their commitment to supporting founders and entrepreneurs in creating, building, and growing companies, demonstrated by successful investments in numerous healthcare companies like Zymeworks (NYSE: ZYME), Repare Therapeutics (NASDAQ: RPTX), and Profound Medical (TSX: PRN).Amplitude Ventures operates with a culture that harmonizes vision and pragmatism, emphasizing the creation of breakthroughs for patients on a sustainable basis. They have active offices in Montreal, Toronto, Vancouver, and Calgary, reaching across Canadian centers of excellence in precision medicine and fostering collaboration to promote sector-leading value and accelerated growth.
We invest in promising healthcare companies that share our vision of bringing groundbreaking technologies to patients. Amplitude is focused on building world-class Canadian companies (and companies associated with Canadian talent and IP) in precision medicine and next-generation medical devices.